MacroGenics
MGNX
135 hedge funds and large institutions have $199M invested in MacroGenics in 2022 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 43 increasing their positions, 50 reducing their positions, and 18 closing their positions.
267% more call options, than puts
Call options by funds: $44K | Put options by funds: $12K
21% more capital invested
Capital invested by funds: $165M → $199M (+$34.4M)
11% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 18
2% more funds holding
Funds holding: 133 → 135 (+2)
8.52% less ownership
Funds ownership: 102.1% → 93.58% (-8.5%)
14% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 50
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$3.57M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
+$3.56M |
| 3 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$2.68M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.51M |
| 5 |
BlackRock
New York
|
+$1.42M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$11.7M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$5.7M |
| 3 |
PA
Perceptive Advisors
New York
|
-$3.62M |
| 4 |
Renaissance Technologies
New York
|
-$3.53M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.4M |
MGNX Hedge Fund Activity: Q3 2022 in Review
135 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q3 2022, worth a combined $199M — up 21% from $165M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new MGNX positions and 18 closed out — a net gain of 2 holders — while 43 added to existing stakes and 50 trimmed.
The largest buyer was Millennium Management, adding an estimated $3.57M. The largest seller was RTW Investments, exiting entirely with an estimated $11.7M sold.
- 135 institutional investors held MacroGenics (MGNX) as of Q3 2022, up from 133 in Q2 2022.
- Funds reported $199M of MacroGenics stock for Q3 2022, up 21% quarter-over-quarter.
- 20 funds opened new MacroGenics positions in Q3 2022 and 18 closed out, a net change of +2 holders.
- The largest MacroGenics buyer in Q3 2022 was Millennium Management, an estimated $3.57M added.
- The largest MacroGenics seller in Q3 2022 was RTW Investments, an estimated $11.7M sold.
Based on aggregated 13F filings for Q3 2022.